InsiderTrades

Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/

Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-30 · accession 0001814145-23-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-03 2023-06-30 KEQU Batdorff Douglas J. VP of Manufacturing Ops F - Tax $15.90 -1,037 10.6K -9% -$16.5K
D 2023-07-03 2023-06-30 KEQU Batdorff Douglas J. VP of Manufacturing Ops M - OptEx $0.00 +3,661 11.6K +46% $0
DM 2023-07-03 2023-06-30 KEQU Batdorff Douglas J. VP of Manufacturing Ops M - OptEx $0.00 -3,661 1,689 -68% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-06-30 F D 1,037 $15.90 10,574 D — —
2 Common Common Stock 2023-06-30 M A 3,661 $0.00 11,611 D — — (F1) Restricted stock units convert to common stock on a one-for-one basis.
3 Derivative Restricted Stock Units FY23 2023-06-30 M D 1,972 $0.00 3,944 D — · — to — 1,972 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) On June 29, 2022, the reporting person was granted restricted stock units that vest as follows: (a) 100% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 30, 2023, subject to the reporting person's continued employment with the Company.
4 Derivative Restricted Stock Units FY22 2023-06-30 M D 1,689 $0.00 1,689 D — · — to — 1,689 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F3) On June 23, 2021, the reporting person was granted restricted stock units that vest as follows: (a) 100% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 30, 2022, subject to the reporting person's continued employment with the Company.